The ACC has collaborated with Medscape to create two Centers of Excellence on the topics of Cardiovascular Risk Reduction and Heart Failure. This collaboration
See more from American College of Cardiology
In a new ACC & @Medscape collaborative piece, Drs. @YHandelsmanMD and @BudoffMd discuss #SGLT2 Inhibitors vs GLP-1 Agonists. Read more about the best practices, latest developments & advantages of combination therapy: https://t.co/D93Q5Q2uyz #HeartFailure - view on twitter